Tag: technology

“COVID Vaccines” and “Genetically Modified Humans”

“Biotechnology can be classified as the cloning of animals with identical genetic composition or genetic engineering (via recombinant DNA technology and gene editing) to produce genetically modified animals or microorganisms. Cloning helps to conserve species and breeds, particularly those with excellent biological and economical traits. Recombinant DNA technology combines genetic materials from multiple sources into single cells to generate proteins. (Journal of Animal Science and Biotechnology)

Genetically-modified organisms can be patented and owned. Monsanto owns the GMO seeds. Once DNA vaccines are used on humans — and it has never been done before — humans could possibly be “owned”. We could in theory be “patented”.

None of this has been discussed at length, and very little about this is known publicly.

No randomized placebo-controlled trials have been conducted. Vaccine manufacturers are exempt from these and many other safeguards.

In 2010, the Defense Advanced Research Projects Agency (DARPA) admitted that this type of technology can be used to “enhance and subvert” humans at a genetic level.

Hydrogel nanotechnology is injected beneath the skin. It can interface with cell phones and Artificial Intelligence to monitor basically everything within the body, including anxieties, emotions, ovulations, vitamins etc. etc.

Once implanted, the technology spreads throughout the body. Scientists do not know how this affects our DNA.

Recombinant RNA and DNA technology will, argues Dr. Madej, cause permanent and unknown genetic changes in a person’s body.

Will it create a new species and destroy an old one?

Keep reading

What could go wrong?ELECTRX has the nerve to envision revolutionary therapies for self-healing

Many chronic inflammatory diseases and mental health conditions affecting military service members and veterans involve abnormal activity in the peripheral nervous system, which plays a key role in organ function. Monitoring and targeted regulation of peripheral nerve signals offer great promise to help patients restore and maintain their health without surgery or drugs. Current neuromodulation devices are typically used as a last resort, however, because they are relatively large (about the size of a deck of cards), require invasive surgical implantation and often produce side effects due to their lack of precision. DARPA’s Electrical Prescriptions (ElectRx) program is seeking innovative research proposals to help transform neuromodulation therapies from last resort to first choice for a wide range of diseases.

ElectRx (pronounced “electrics”) aims to develop groundbreaking technologies that would use the body’s innate neurophysiology to restore and maintain health. In support of the White House’s brain initiative, ElectRx also seeks to accelerate understanding of specific neural circuits and their role in health and disease. Future therapies based on targeted peripheral neural stimulation could promote self-healing, reduce dependence on traditional drugs and provide new treatment options for illnesses.

ElectRx would leverage advanced sensing and stimulating technologies to target specific peripheral neural circuits that control organ functions. These feedback-controlled neuromodulation technologies would monitor health status and intervene as needed to deliver patient-specific therapeutic patterns of stimulation designed to restore a healthy physiological state. The program seeks to create ultraminiaturized devices that would require only minimally invasive insertion procedures such as injectable delivery through a needle.

Keep reading

For The First Time, CRISPR Gene-Editing Has Been Used on Squid

For the first time, the innovative CRISPR gene editing method has been used on squid, marking a milestone in the scientific study of these creatures – and opening up many new areas of potential research.

CRISPR enables very precise, speedy, and low-cost DNA edits. Put simple, the ingenious molecular workings of the method are often described as something that allows us to ‘cut’ and ‘paste’ genes; in humans it promises to give us a way of tackling disease and killing superbugs at the genetic level.

In this case CRISPR-Cas9 genome editing was used on Doryteuthis pealeii (the longfin inshore squid) to disable a pigmentation gene, turning off the pigmentation usually found in the squid eye and inside specialised skin cells called chromatophores.

“This is a critical first step toward the ability to knock out – and knock in – genes in cephalopods to address a host of biological questions,” says marine biologist Joshua Rosenthal, from the Marine Biological Laboratory (MBL) at the University of Chicago.

Keep reading